大洋生物(003017.SZ)：汪贤高拟减持不超过0.68%股份

Core Viewpoint - The major shareholder, Mr. Wang Xiangao, plans to reduce his stake in Dayang Bio (003017.SZ) by selling up to 570,000 shares, which represents 0.68% of the company's total shares, within a specified period [1] Summary by Category - Shareholder Reduction Plan - Mr. Wang Xiangao intends to reduce his holdings by a maximum of 570,000 shares through centralized bidding transactions [1] - The reduction period is set from January 12, 2026, to April 11, 2026, excluding any periods during which reductions are prohibited by the China Securities Regulatory Commission or the Shenzhen Stock Exchange [1]